Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: Study protocol for a randomized controlled trial (AKIKI)

Trials

Volumn 16, Issue 1, 2015, Pages

  Gaudry, Stéphane ^a,b   Hajage, David ^a,c,d   Schortgen, Fréderique ^v   Martin Lefevre, Laurent ^e   Tubach, Florence ^c,d,f   Pons, Bertrand ^g   Boulet, Eric ^h   Boyer, Alexandre ⁱ   Lerolle, Nicolas ^j   Chevrel, Guillaume ^k   Carpentier, Dorothée ^l   Lautrette, Alexandre ^m   Bretagnol, Anne ⁿ   Mayaux, Julien ^o   Thirion, Marina ^p   Markowicz, Philippe ^q   Thomas, Guillemette ^r   Dellamonica, Jean ^s   Richecoeur, Jack ^t   Darmon, Michael ^u   Prost, Nicolas ^v,w   Yonis, Hodane ^x   Megarbane, Bruno ^y   Loubières, Yann ^z   Blayau, Clarisse ^aa   Maizel, Julien ^c   Zuber, Benjamin ^ab   Nseir, Saad ^ac   Bigé, Naïke ^ad   Hoffmann, Isabelle ^c,f   Ricard, Jean Damien ^a,ae   Dreyfuss, Didier ^a,ae   more..

^a HÔPITAL LOUIS MOURIER   (France)

^b Paris Diderot University   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Medical Surgical Intensive Care Unit District Hospital Center   (France)

^f BICHAT HOSPITAL   (France)

^g Service de Dermatologie Maladies Infectieuses   (France)

^h CENTRE HOSPITALIER RENÉ DUBOS   (France)

ⁱ HÔPITAL PELLEGRIN   (France)

^j UNIVERSITÉ D'ANGERS   (France)

^k CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^l ROUEN UNIVERSITY HOSPITAL   (France)

^m SERVICE DE RHUMATOLOGIE   (France)

ⁿ CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^o PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^p Réanimation polyvalente   (France)

^q CH Cholet   (France)

^r HÔPITAL NORD   (France)

^s CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^t Hôpital de Beauvais   (France)

^u UNIVERSITÉ JEAN MONNET   (France)

^v HENRI MONDOR HOSPITAL   (France)

^w UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^x CROIX ROUSSE HOSPITAL   (France)

^y UMR S 1144   (France)

^z EMSP CH Poissy Saint Germain en Laye   (France)

^aa ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^ab CH Versailles   (France)

^ac LILLE UNIVERSITY HOSPITAL   (France)

^ad HÔPITAL SAINT ANTOINE   (France)

^ae UNIVERSITÉ PARIS DIDEROT   (France)

more..

Author keywords

Acute kidney injury; Critical care; Renal replacement therapy; Treatment outcome

Indexed keywords

CATECHOLAMINE; DIURETIC AGENT; POTASSIUM; UREA; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ANURIA; ARTERIAL BLOOD; ARTERIAL PH; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CRITICALLY ILL PATIENT; DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIURETIC THERAPY; FLOW RATE; FLUID THERAPY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERVOLEMIA; HYPOXEMIA; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG VENTILATION; METABOLIC ACIDOSIS; MORTALITY; MULTICENTER STUDY; OVERALL SURVIVAL; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SAMPLE SIZE; TREATMENT OUTCOME; UREA BLOOD LEVEL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DECISION SUPPORT SYSTEM; FRANCE; INJURY SCALE; METHODOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TIME TO TREATMENT;

ACUTE KIDNEY INJURY; BIOMARKERS; CLINICAL PROTOCOLS; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; FRANCE; HUMANS; INJURY SEVERITY SCORE; INTENSIVE CARE UNITS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84928552678     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0718-x     Document Type: Article

References (28)

1. Hoste EAJ, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 2008;36:S146-51.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813-8.
3. De Mendonça A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915-21.
4. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med. 2000;162:197-202.
5. Ympa YP, Sakr Y, Reinhart K, Vincent J-L. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med. 2005;118:827-32.
6. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, et al. An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med. 2010;181:1128-55.
7. Section 5: dialysis interventions for treatment of AKI. Kidney Int Suppl. (2011). 2012; 2(1):89-115.
8. Yang Y-X, Lewis JD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis. 2003;14:11-9.
9. Faisy C, Guerot E, Diehl J-L, Iftimovici E, Fagon J-Y. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med. 2003;29:1306-13.
10. Bagshaw SM, Cruz DN, Gibney RTN, Ronco C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit Care. 2009;13:317.
11. Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Crit Care. 2011;15:223.
12. Ricci Z, Ronco C. Timing, dose and mode of dialysis in acute kidney injury. Curr Opin Crit Care. 2011;17:556-61.
13. Elseviers MM, Lins RL, Van der Niepen P, Hoste E, Malbrain ML, Damas P, et al. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care. 2010;14:R221.
14. Vinsonneau C, Monchi M. Too early initiation of renal replacement therapy may be harmful. Crit Care. 2011;15:112.
15. Schneider AG, Uchino S, Bellomo R. Severe acute kidney injury not treated with renal replacement therapy: characteristics and outcome. Nephrol Dial Transplant. 2012;27:947-52.
16. Gaudry S, Ricard J-D, Leclaire C, Rafat C, Messika J, Bedet A, et al. Acute kidney injury in critical care: experience of a conservative strategy. J Crit Care. 2014;29(6):1022-7.
17. Clark E, Wald R, Walsh M, Bagshaw SM, Canadian Acute Kidney Injury (CANAKI) Investigators. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant. 2012;27:2761-7.
18. Barbar SD, Binquet C, Monchi M, Bruyère R, Quenot J-P. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial. Trials. 2014;15:270.
19. Smith OM, Wald R, Adhikari NKJ, Pope K, Weir MA, Bagshaw SM, et al. Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial. Trials. 2013;14:320.
20. Section 2: AKI definition. Kidney Int Suppl. (2011). 2012;2(1):19-36.
21. Vinsonneau C, Allain-Launay E, blayau C, Darmon M, du Cheyron D, Gaillot T, et al. Épuration extrarénale en réanimation adulte et pédiatrique. Recommandations formalisées d'experts sous l'égide de la Société de réanimation de langue française (SRLF), avec la participation de la Société française d'anesthésie-réanimation (Sfar), du Groupe francophone de réanimation et urgences pédiatriques (GFRUP)et de la Société francophone de dialyse (SFD). Réanimation. 2014; 23:714-37.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-70.
23. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med. 2012;157:429-38.
24. Vinsonneau C, Camus C, Combes A, de Beauregard MAC, Klouche K, Boulain T, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368:379-85.
25. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-38.
26. Bouman CSC, Oudemans-Van Straaten HM, Tijssen JGP, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205-11.
27. Karrison TG, Huo D, Chappell R. A group sequential, response-adaptive design for randomized clinical trials. Control Clin Trials. 2003;24:506-22.
28. Wilson FP. A policy of preemption: the timing of renal replacement therapy in AKI. Clin J Am Soc Nephrol. 2014;9:1510-2.